NCT02541162

Brief Summary

In a perspective of improvement of the global care of the patients, investigators wish to estimate, within the oncology department of Paris Saint Joseph Hospital, the impact of a clear, written and oral information, on the sexual satisfaction of the couples during treatments. Further to this study, the project will be to train and to sensitize the medical staff, or still to develop new activities to meet the needs better of patients and of partners.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable cancer

Timeline
Completed

Started Jun 2014

Typical duration for not_applicable cancer

Geographic Reach
1 country

2 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 11, 2014

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

August 21, 2015

Completed
14 days until next milestone

First Posted

Study publicly available on registry

September 4, 2015

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 15, 2015

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 15, 2017

Completed
Last Updated

March 14, 2018

Status Verified

March 1, 2018

Enrollment Period

1.3 years

First QC Date

August 21, 2015

Last Update Submit

March 12, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change from baseline in Quality Life (QLQ C30) due to a specific information about the sexuality on the sexual satisfaction of the couples, assessed

    3 times points: Randomization (Day 1), 2 months and 6 months post-inclusion

    Participants will be followed during 6 months

Secondary Outcomes (1)

  • Change from baseline in Sexual Satisfaction Score (ESS) due to a specific information about the sexuality on the sexual satisfaction of the couples, assessed

    Participants will be followed during 6 months

Study Arms (2)

INFORMED

EXPERIMENTAL

Interventional Group (I): Couples enrolled during the diagnosis will receive written information as usual about the disease and in addition they benefit special oral interviews and written information about experiences of their sexuality during the illness.The document used for the interventional group is "Sexuality and Cancer" and will be given to couples. (intervention: Oral information and interviews about sexuality and self experience during the disease). Qualitative analysis will be provided by a psychologist

Behavioral: Oral information and interviews

ORDINARY USE

NO INTERVENTION

Non-interventional Group (NI): Couples enrolled during the diagnosis will only receive written information about their experience of disease . The document used fot the non interventional group is "Live during and after cancer"and will be given to couples. Qualitative analysis will be provided by a psychologist

Interventions

interviews about sexuality and self experience during the disease

INFORMED

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients and partners declaring itself in couple or having a shared private life;
  • Patients diagnosed by an initial cancer, the prognosis for survival of which at the time of the diagnosis is upper to one year;
  • Patients and partners of more than 18 years old, mastering the French language, and in measure to give their informed consent

You may not qualify if:

  • Patients having been diagnosed and/or treated for another cancer;
  • Patients and partners having a psychiatric disorder (confusional syndrome, psychotic disorders, disrupted reality perception)
  • Patients and partners protected by the law, according to articles L.1121-5 to L.1121-8 of the Public health code.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

hopital Saint Joseph

Paris, 75014, France

Location

Groupe Hospitalier Paris Saint Joseph

Paris, Île-de-France Region, 75014, France

Location

MeSH Terms

Conditions

Neoplasms

Interventions

Interviews as Topic

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Helene Beaussier, Pharm D

    CRC - GHPSJ

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 21, 2015

First Posted

September 4, 2015

Study Start

June 11, 2014

Primary Completion

October 15, 2015

Study Completion

October 15, 2017

Last Updated

March 14, 2018

Record last verified: 2018-03

Locations